Saju 2021.
Study name | Swāsthya, an integrated chronic condition management programme for families of patients with hypertension and diabetes mellitus |
Methods |
Study design: cluster‐RCT Country: India |
Participants | Families of patients with hypertension and diabetes mellitus Inclusion criteria: a. Eligible families will be those with at least one family member with a confirmed diagnosis of HTN and/or DM. b. Family members must be either first‐degree blood relatives or spouses of the patient. Exclusion criteria: a. bedridden and terminally ill patients Stated purpose: to improve treatment adherence and medical compliance by addressing social, behavioural, and cognitive barriers to ensure the control of chronic conditions such as HTN and DM |
Interventions |
Intervention: Swāsthya intervention (social, behavioural, and cognitive or multiple interventions) The package comprising five separate modules on general, behavioural, social, cognitive, and multiple interventions prepared by the research team. General interventions will be delivered to all participants included in the intervention arm. Behavioural, social, and cognitive interventions will be separately administered to participants based on the group they belong to (behavioural risk, social risk and cognitive risk groups). For the fourth group, that is, the multiple risk groups, interventions will be customised based on their priority needs. All the interventions are developed targeting the entire family. Control: Usual care (patients with HTN and/or DM in the control arm will be referred to PHCs or encouraged to access their preferred health care facility) |
Outcomes |
Participants'outcomes of interest for this review
Economic outcomes Nil Time points: baseline, post‐intervention (6 months and 12 months post‐baseline) |
Starting date | 1 February 2021 (recruitment start date) |
Contact information | M D Saju, saju@rajagiri.edu or sajumadavan@gmail.com |
Notes |
Source of funding: Rajagiri College of Social Sciences (Autonomous) and IMPRESS, ICSSR under the grant number IMPRESS/P798/2045/2018‐19/ICSSR Prospective trial registration number: CTRI/2020/12/029474 |